Medicare, Medicaid to cover obesity drugs
This is a news story, published by NBC News, that relates primarily to Biden news.
Biden news
For more Biden news, you can click here:
more Biden newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsNBC News news
For more news from NBC News, you can click here:
more news from NBC NewsAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
Medicaid. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Medicaid populations news, weight loss drugs news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
weight loss medicationsNBC News
•Biden proposes requiring Medicare, Medicaid to cover weight loss drugs
84% Informative
The Biden administration plans to require Medicare and Medicaid to offer coverage of weight loss medications for patients seeking to treat obesity.
The new rule would dramatically expand access to anti-obesity medications like Wegovy, Ozempic and Mounjaro .
Today , a month 's supply of weight-loss drugs can cost $ 1,000 or more, White House official says.
VR Score
84
Informative language
83
Neutral language
60
Article tone
formal
Language
English
Language complexity
58
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
3
Source diversity
3
Affiliate links
no affiliate links